Biotech companies in funding overdrive during second quarter
Despite the fact that biotech share values were heading south at the beginning of the second quarter of 2014, the short-lived negative environment failed to scare off investors completely, with companies maintaining the momentum built from the first quarter, as far as raising cash is concerned.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter